A Functional Perspective
Executive Summary
Most people are told a simple story: high cholesterol causes heart disease, and lowering LDL with statins is the safest solution. This story is comforting because it offers certainty and control. It is also incomplete.
Cholesterol is not a toxin or waste product. It is a critical repair, signaling, and structural molecule used by every cell in the body, especially the brain, the immune system, and hormone-producing tissues. LDL becomes harmful only in a specific biological context – when blood sugar regulation is impaired, inflammation is chronically elevated, blood vessels are damaged, and metabolic stress is ongoing. In low-inflammation, metabolically stable states, LDL often circulates without causing harm.
Statins lower cholesterol by blocking its production in the liver. In people with established cardiovascular disease or very high baseline risk, this can reduce future events. But the same pathway statins block also produces CoQ10, a molecule essential for cellular energy. Over time, this can reduce energy production, slow muscle recovery, impair exercise tolerance, and worsen insulin resistance, increasing the risk of type 2 diabetes.
These effects matter because long-term cardiovascular protection depends far more on metabolic health, muscle mass, insulin sensitivity, stress resilience, and vascular function than on LDL alone. Any intervention that quietly reduces energy, worsens glucose control, or erodes physiological reserve can make the most powerful protective strategies – movement, strength, and lifestyle change – harder to sustain.
A functional approach asks a different question: why is cholesterol elevated in the first place? Common drivers include insulin resistance, chronic inflammation, stress hormone activation, poor sleep, liver congestion, and impaired mitochondrial function. When these are corrected, cholesterol often improves naturally, without suppressing essential biological pathways.
Statins are not inherently good or bad. They are tools. For high-risk individuals, they may be appropriate. For lower-risk professionals, the long-term trade-offs deserve thoughtful, individualized consideration.
The true goal is not perfect cholesterol numbers. The goal is a body that produces energy efficiently, maintains muscle and metabolic health, adapts to stress, and protects the heart over decades – not just years.
What Cholesterol Really Is
Cholesterol is fundamental to human biology. Every cell membrane relies on cholesterol for strength, flexibility, and communication. The brain, which is one of the most cholesterol-dense organs in the body, depends on it for memory formation, learning, and neural repair. Cholesterol is also the raw material for steroid hormones, vitamin D, bile acids needed for digestion, and signaling molecules that regulate immunity and inflammation.
Because cholesterol is not water-soluble, it travels through the bloodstream packaged inside lipoproteins. LDL and HDL are not substances themselves; they are transport vehicles. Their role is to deliver cholesterol where it is needed and return excess cholesterol to the liver for recycling.
Problems arise not because LDL exists, but because LDL particles become excessive in number, structurally damaged, or trapped in inflamed vessel walls. This is why total cholesterol and LDL concentration alone provide an incomplete and often misleading picture of cardiovascular risk.
How and Why Excess Cholesterol and LDL Develop – and When They Are Harmful
Elevated cholesterol is usually an adaptive response to internal stress. The liver increases cholesterol production when the body needs repair, hormonal support, immune defense, or structural reinforcement. Metabolic instability, tissue damage, inflammation, and chronic stress all signal the liver to produce more cholesterol as part of a protective strategy.
One of the strongest drivers of elevated LDL is insulin resistance. When cells stop responding efficiently to insulin, the liver alters how it packages and exports fat and cholesterol. LDL particle number rises, triglycerides increase, and HDL often falls. This pattern reflects metabolic congestion and impaired fuel handling rather than excess dietary cholesterol.
Chronic inflammation is another major driver. Cholesterol and LDL particles play roles in innate immunity, binding toxins and damaged molecules. Inflammatory signaling tells the liver to increase lipoprotein output because cholesterol is needed for defense and repair. In this context, higher LDL is a downstream effect, not the primary problem.
Stress hormones further amplify this process. Cortisol and adrenaline increase cholesterol synthesis because cholesterol is the raw material for steroid hormones. Chronic psychological stress, poor sleep, circadian disruption, and excessive training without recovery all push cholesterol upward through this mechanism.
LDL becomes dangerous not when it is simply elevated, but when it circulates in a damaged biological environment. When blood sugar and insulin are persistently high, LDL particles become glycated and oxidized. When oxidative stress overwhelms antioxidant defenses, LDL becomes structurally unstable. When the inner lining of blood vessels is inflamed or injured, LDL particles are more likely to penetrate and become trapped.
By contrast, in metabolically healthy states – where blood sugar is stable, inflammation is low, antioxidant systems are robust, and blood vessels are flexible – LDL often performs its transport role without causing harm. This explains why some individuals with high LDL never develop cardiovascular disease, while others with “normal” cholesterol do. The difference is context, not the number.
The Functional Approach to Cholesterol Balance and Healing
A functional approach does not begin by asking how to suppress LDL. It begins by asking why the body believes it needs elevated LDL in the first place.
Balancing cholesterol means correcting the upstream signals driving overproduction and damage. This involves restoring insulin sensitivity so the liver no longer overproduces lipoproteins. It means calming chronic inflammation so LDL is no longer recruited as a repair molecule. It requires supporting liver function so cholesterol transport, conversion to bile, and recycling work efficiently. It also depends on restoring mitochondrial energy production so cells stop signaling distress.
When these systems recover, cholesterol often normalizes without force. LDL particle quality improves. Triglycerides fall. HDL rises. Vascular inflammation quiets. Cholesterol is not suppressed; it is re-regulated. This is fundamentally different from blocking a pathway. It is about restoring biological coherence so compensation is no longer required.
Why Statins Were Introduced
Statins reduce cholesterol by inhibiting a liver enzyme that controls the first major step in cholesterol synthesis. When this enzyme is blocked, cholesterol production falls and LDL particles are removed more aggressively from the bloodstream.
In people with established cardiovascular disease, this reduction can lower the risk of future events. In high-risk populations, the benefit can be clinically meaningful. But this same biochemical pathway also produces molecules essential for normal cellular function, particularly Coenzyme Q10.
What the Evidence Shows – and What It Often Misses
Clinical trials consistently show reductions in relative cardiovascular risk with statin use. But relative risk can exaggerate perceived benefit. When absolute risk is examined, the benefit for low-risk individuals is often small.
What receives far less attention is how statins influence mitochondrial function, muscle biology, glucose metabolism, and energy production over time. These effects rarely appear as dramatic adverse events in trials, yet they accumulate gradually and shape a person’s capacity to remain active, metabolically flexible, and resilient with age.
The functional question is not whether statins lower LDL. It is whether they improve or compromise the system as a whole.
CoQ10 Depletion and Energy Loss
CoQ10 is central to mitochondrial energy production. It allows electrons to move efficiently through the energy-producing machinery of the cell, converting food into ATP. The cholesterol synthesis pathway blocked by statins is the same pathway that produces CoQ10.
When this pathway is inhibited, CoQ10 levels fall, particularly in high-energy tissues such as muscle, heart, and brain. Over time, this reduces cellular energy efficiency, slows recovery after exercise, increases fatigue, and can impair cardiac muscle energetics.
Even when muscle pain is mild or absent, energy output may still be reduced. This is crucial because exercise and strength training are among the most powerful interventions for improving insulin sensitivity, reducing inflammation, maintaining muscle mass, and protecting cardiovascular health. When movement feels harder, adherence declines – not because of motivation failure, but because biology has made effort more expensive.
Statins, Insulin Resistance, and Diabetes Risk
Statin use is consistently associated with increased risk of type 2 diabetes, particularly in individuals already metabolically vulnerable. This is not incidental. Statins reduce insulin sensitivity in muscle and liver tissue and impair mitochondrial glucose utilization. As a result, the pancreas must produce more insulin to maintain blood sugar control, accelerating insulin resistance over time.
This creates a paradox. LDL levels may improve, while the metabolic conditions that drive cardiovascular disease – insulin resistance and chronic inflammation – worsen. For individuals already struggling with fatigue, weight gain, or rising glucose, this can make lifestyle change feel like constant resistance.
Why Side Effects Accumulate Over Time
Statin side effects are rarely dramatic. They are cumulative. Slight reductions in energy, slower recovery, subtle glucose dysregulation, muscle stiffness, and sleep disturbance gradually reduce physiological reserve.
Reduced reserve means exercise becomes inconsistent, muscle mass declines faster with age, insulin resistance deepens, fat accumulation becomes easier, and motivation erodes because effort no longer yields proportional reward. None of this is visible on a cholesterol panel, yet it profoundly influences long-term cardiovascular and metabolic outcomes.
Where Cholesterol-Only Thinking Fails
Heart attacks do not occur because cholesterol floats harmlessly in the blood. They occur when inflamed, metabolically damaged vessels encounter unstable plaques under stress. Blood sugar instability, visceral fat, sleep deprivation, chronic stress, and poor recovery weaken vascular resilience. Lowering LDL without addressing these drivers is cosmetic rather than corrective.
A Functional Perspective on Cardiovascular Protection
A functional approach does not reject statins outright. It places them in context. The central question becomes whether an intervention supports or undermines the body’s ability to restore metabolic balance, preserve muscle, maintain energy, and adapt to stress.
For many individuals, improving diet quality, rebuilding muscle, restoring sleep and circadian rhythm, regulating stress, and calming inflammation provides broader and more durable protection than LDL suppression alone. For those who do use statins, careful attention to metabolic markers, mitochondrial health, and muscle preservation becomes essential.
Longevity is not achieved by suppressing one pathway. It is achieved by keeping systems adaptable, energized, and responsive.
So Should You Take a Statin?
This is not a moral decision. It is a biological one. For high-risk individuals with established disease, statins may reduce future events. For lower-risk professionals, the long-term trade-offs deserve careful evaluation – especially if side effects interfere with the very behaviors that provide the greatest protection.
The most dangerous position is not taking or refusing a statin. It is never examining how it interacts with your unique metabolism, stress load, and capacity for change.
Final Thoughts
Cholesterol is not the enemy. Statins are not villains. But reducing cardiovascular disease to a single lab number ignores how the body actually functions.
When energy production declines, insulin resistance rises, and resilience erodes, lifestyle change becomes harder – not easier. And sustained lifestyle change remains the most powerful driver of cardiovascular protection and longevity.
The goal is not perfect cholesterol. The goal is a body that produces energy efficiently, repairs itself, adapts to stress, and remains metabolically flexible with age.
That is the difference between managing risk and building health.
About Mathew Gomes
Functional Health, Nutrition & Longevity Coach
Mathew Gomes is a Functional Health, Nutrition & Longevity Coach helping busy professionals reverse early health decline before it becomes disease. Trained in Functional Nutrition Coaching (AAFH) and certified in executive coaching (ICF, EMCC), with an engineering background and MBA, he brings systems thinking and strategic clarity to health restoration.
Shaped by senior leadership experience and a personal health crisis, Mathew uses functional assessment and targeted testing to identify root causes and coordinate personalised nutrition, metabolic repair, strength training, nervous-system regulation, sleep and recovery. He works alongside doctors for diagnosis and medication while building resilient, sustainable health—so clients regain energy, focus and confidence without guesswork.
References
Bergman, R.N., Kim, S.P., Hsu, I.R. et al. (2007) ‘Abdominal obesity: role in the pathophysiology of metabolic disease and cardiovascular risk’, The American Journal of Medicine, 120(2), pp. S3–S8.
Bickman, B. (2020) Why We Get Sick: The Hidden Epidemic at the Root of Most Chronic Disease – and How to Fight It. Dallas, TX: BenBella Books.
Bland, J.S. (2017) The Disease Delusion: Conquering the Causes of Chronic Illness for a Healthier, Longer, and Happier Life. Columbus, OH: Lifestyle Medicine Press.
Brewer, L.C. and Jones, D.W. (2016) ‘The pathophysiology of atherosclerosis: insights from systems biology’, Journal of the American College of Cardiology, 67(16), pp. 1912–1925.
Ford, E.S., Li, C. and Sattar, N. (2008) ‘Metabolic syndrome and incident diabetes’, Diabetes Care, 31(9), pp. 1898–1904.
Framingham Heart Study Investigators (2015) ‘Triglycerides, HDL, LDL particle number and cardiovascular risk’, Circulation, 132(10), pp. 934–944.
Hyman, M. (2014) The Blood Sugar Solution. New York: Little, Brown and Company.
Disclaimer
This white paper is provided for educational and informational purposes only. It is not intended to diagnose, treat, cure, prevent, or provide medical advice for any disease or health condition.
The author is a Functional Health, Nutrition and Longevity Coach, not a medical doctor. The content presented reflects a functional, educational perspective on health, lifestyle, nutrition, and risk factors, and is designed to support informed self-care and productive conversations with qualified healthcare professionals. Nothing in this document should be interpreted as a substitute for medical advice, diagnosis, or treatment from a licensed physician or other qualified healthcare provider. Readers should not start, stop, or change any medication, supplement, or medical treatment without consulting their prescribing clinician.
Individual responses to nutrition, lifestyle, supplements, and coaching strategies vary. Any actions taken based on this information are done at the reader’s own discretion and responsibility. If you have a medical condition, are taking prescription medication, or have concerns about your health, you are advised to seek guidance from a licensed healthcare professional before making changes.
Pingback: Transforming Heart Health - Functional Health & Longevity Blogs | Mathew Gomes